Date: Sep 19, 2010 Source: Mass Device (
click here to go to the source)
BSD Medical Corp. lands 510(k) clearance from the Food & Drug Administration for its MTX-180 microwave ablation system and drums up $2.75 million in an offering of stock and warrants to a pair of its previous institutional investors.
BSDM logo
BSD Medical Corp. (NSDQ:BSDM) landed 510(k) clearance from the Food & Drug Administration for itsits MicroThermX microwave ablation system, MTX-180.
The Salt Lake City-based cancer treatment device-maker said it optimized the MTX-180 system with higher power for interventional and surgical oncology. The device uses "synchronous phased array technology" to target microwave energy for soft-tissue ablation.
